HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 167 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $106,000 | +37.7% | 5,949 | +20.4% | 0.00% | 0.0% |
Q3 2019 | $77,000 | -7.2% | 4,939 | +2.9% | 0.00% | 0.0% |
Q2 2019 | $83,000 | +33.9% | 4,800 | +25.2% | 0.00% | – |
Q1 2019 | $62,000 | +10.7% | 3,833 | -0.8% | 0.00% | -100.0% |
Q4 2018 | $56,000 | -15.2% | 3,862 | +5.7% | 0.00% | 0.0% |
Q3 2018 | $66,000 | +500.0% | 3,653 | +548.8% | 0.00% | – |
Q2 2018 | $11,000 | 0.0% | 563 | 0.0% | 0.00% | – |
Q1 2018 | $11,000 | +10.0% | 563 | +9.5% | 0.00% | – |
Q4 2017 | $10,000 | +42.9% | 514 | +24.2% | 0.00% | – |
Q3 2017 | $7,000 | +250.0% | 414 | +94.4% | 0.00% | – |
Q2 2017 | $2,000 | +100.0% | 213 | +113.0% | 0.00% | – |
Q1 2017 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q4 2016 | $1,000 | -98.1% | 100 | -97.7% | 0.00% | -100.0% |
Q3 2016 | $52,000 | +48.6% | 4,300 | +7.5% | 0.00% | 0.0% |
Q2 2016 | $35,000 | -7.9% | 4,000 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $38,000 | -44.9% | 4,000 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $69,000 | -1.4% | 4,000 | -23.1% | 0.00% | 0.0% |
Q3 2015 | $70,000 | -9.1% | 5,200 | +52.9% | 0.00% | 0.0% |
Q2 2015 | $77,000 | +57.1% | 3,400 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $49,000 | +48.5% | 3,400 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $33,000 | +200.0% | 3,400 | +183.3% | 0.00% | – |
Q3 2014 | $11,000 | +450.0% | 1,200 | +500.0% | 0.00% | – |
Q2 2014 | $2,000 | -33.3% | 200 | 0.0% | 0.00% | – |
Q1 2014 | $3,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |